AIM
ABBV icon

Axiom Investment Management’s AbbVie ABBV Stock Holding History

Axiom Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
4,806
+111
+2% +$23.9K 0.81% 37
2026
Q1 		$1.02M Buy
+4,695
New +$1.04M 0.78% 36
2022
Q4 		$1.36M Buy
8,386
+1,023
+14% +$157K 3.53% 6
2022
Q3 		$988K Buy
7,363
+23
+0.3% +$3.3K 1.97% 9
2022
Q2 		$1.12M Buy
7,340
+21
+0.3% +$3.21K 3.23% 6
2022
Q1 		$1.19M Sell
7,319
-410
-5% -$59.6K 2.58% 9
2021
Q4 		$1.05M Sell
7,729
-725
-9% -$85.6K 1.01% 21
2021
Q3 		$912K Buy
8,454
+26
+0.3% +$2.97K 0.92% 24
2021
Q2 		$949K Sell
8,428
-4,475
-35% -$504K 0.74% 38
2021
Q1 		$1.4M Buy
12,903
+12,368
+2,312% +$1.32M 1.14% 17
2020
Q4 		$480K Sell
535
-9,065
-94% -$871K 0.44% 54
2020
Q3 		$841K Sell
9,600
-317
-3% -$29.8K 0.95% 29
2020
Q2 		$974K Buy
9,917
+5,286
+114% +$465K 1.29% 23
2020
Q1 		$353K Sell
4,631
-43
-0.9% -$3.66K 0.62% 50
2019
Q4 		$414K Sell
4,674
-13,105
-74% -$1.09M 0.59% 54
2019
Q3 		$1.35M Sell
17,779
-36,521
-67% -$2.5M 1.03% 26
2019
Q2 		$3.96M Buy
54,300
+1,882
+4% +$148K 0.72% 32
2019
Q1 		$4.22M Buy
52,418
+2,959
+6% +$242K 0.8% 28
2018
Q4 		$4.56M Buy
+49,459
New +$4.35M 0.96% 25

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Axiom Investment Management's ABBV Position: Q2 2026 in Review

Axiom Investment Management increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $23.9K and bringing the position to 4,806 shares worth $1.21M. The position accounts for 0.81% of the portfolio, ranked #37.

Axiom Investment Management first reported a position in ABBV in Q4 2018 and has held it in 19 quarters since. The position peaked at $4.56M in Q4 2018. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Axiom Investment Management held 4,806 shares of AbbVie worth $1.21M as of Q2 2026.
  • Axiom Investment Management bought 111 AbbVie shares in Q2 2026, an estimated $23.9K.
  • AbbVie made up 0.81% of Axiom Investment Management's portfolio in Q2 2026, its #37 holding.
  • Axiom Investment Management first reported a position in AbbVie in Q4 2018 and has held it in 19 quarters since.
  • Axiom Investment Management's AbbVie position peaked at $4.56M in Q4 2018.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.